Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
55.6M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
171K
-
Shares change
-
+71.9K
-
Total reported value, excl. options
-
$63.2K
-
Value change
-
+$10.4K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$0.37
Significant Holders of Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA) as of Q1 2025
10 filings reported holding PCSA - Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q1 2025.
Processa Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (PCSA) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171K shares
of 55.6M outstanding shares and own 0.31% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (56K shares), Virtu Financial LLC (43.2K shares), GEODE CAPITAL MANAGEMENT, LLC (34.4K shares), VANGUARD GROUP INC (24.4K shares), Miracle Mile Advisors, LLC (10K shares), Tower Research Capital LLC (TRC) (2.47K shares), WELLS FARGO & COMPANY/MN (154 shares), UBS Group AG (56 shares), BANK OF AMERICA CORP /DE/ (37 shares), and HRT FINANCIAL LP (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.